Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D2215
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 532 $2,389,070 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $2,389,070 Current and potential, with all options
- Last date to order 10% complete
- IDV ceiling <1% used
- $999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp. to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This IDC, which runs through December 2036, serves as a prime vehicle for delivering critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The contract was awarded through an open competition, with no set-aside requirements, to enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. In addition to the DLA contract, AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The original solicitation, expected to be issued in March 2024, seeks to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, United States Coast Guard, and US Naval Fleet. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The government intends to make multiple primary supplier awards for separate regions (North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet) as well as a single backup supplier award, with the goal of having at least three different contractors to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.
Task orders
Show 40 more
Latest 50 of 532 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D2215?
SPE2DR25D2215 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 1, 2025.
How much is contract SPE2DR25D2215 worth?
Orders under SPE2DR25D2215 have obligated $2,389,070. SPE2DR25D2215's own ceiling is $999,999,999.
How many orders have been placed under contract SPE2DR25D2215?
532 orders have been placed under SPE2DR25D2215, the latest on July 29, 2026.
Who can order from contract SPE2DR25D2215?
SPE2DR25D2215 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D2215 competed?
The extent of competition for SPE2DR25D2215 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV